Brief: Psyence Announces Business Combination Between Wholly Owned Subsidiary Psyence Biomed Corp
09/01/2023 23:17
Jan 9 (Reuters) - Psyence Group Inc PSYG.CD :
* PSYENCE ANNOUNCES BUSINESS COMBINATION BETWEEN WHOLLY
OWNED
SUBSIDIARY PSYENCE BIOMED CORP. AND NASDAQ LISTED NEWCOURT
ACQUISITION CORP
* PSYENCE GROUP INC - UPON CLOSING OF BUSINESS COMBINATION,
PSYENCE BIOMED WOULD EXPECT TO RECEIVE A MINIMUM OF USD$20
MILLION OF CASH HELD IN TRUST
* PSYENCE GROUP INC - BUSINESS COMBINATION REFLECTS A
PRE-MONEY
EQUITY VALUE OF USD$50 MILLION FOR PSYENCE BIOMED
Source text for Eikon: ID:nGNX527Vpg
Further company coverage: PSYG.CD
((reuters.briefs@thomsonreuters.com;))
Recent news on Psyence
See all newsBrief: Psyence Group To Consolidate Shares 15 To 1 Effective April 23, 2025
Brief: Psyence Group Enters Into Debt-For-Equity Swap Agreement With Its Nasdaq-Listed Associate, Psyence Biomedical
Brief: Psyence Biomed Enters Into Agreement To Acquire Stake In Psylabs
Brief: Psyence Biomedical Ltd. Approved To List On Nasdaq Following Completion Of Business Combination Agreement With Newcourt Acquisition Corp
MGC Pharmaceuticals - September 2023 Quarter Activity Report